Institution · GlaxoSmithKline (United Kingdom)
Most cited papers from GlaxoSmithKline (United Kingdom)
What are the most cited papers from GlaxoSmithKline (United Kingdom)?
The most cited paper from GlaxoSmithKline (United Kingdom) is "New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)" (E. A. Eisenhauer, P. Therasse, Jan Bogaerts et al., 2008), with 30,125 citations. Next come "Finding the missing heritability of complex diseases" (8,637) and "Molecular Properties That Influence the Oral Bioavailability of Drug Candidates" (8,390).
Showing 50 of 59 papers. Every paper with more than 2,002 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) E. A. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer | 27 Dec 2008 | 30,125 |
| 2 | Finding the missing heritability of complex diseases Teri A. Manolio et al. · Nature | Oct 2009 | 8,637 |
| 3 | Molecular Properties That Influence the Oral Bioavailability of Drug Candidates Daniel F. Veber, Stephen R. Johnson, Hung‐Yuan Cheng et al. · Journal of Medicinal Chemistry | 11 May 2002 | 8,390 |
| 4 | SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials An‐Wen Chan, Jennifer Tetzlaff, Douglas G. Altman et al. · Annals of Internal Medicine | 5 Feb 2013 | 8,142 |
| 5 | Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 Mohammad Hossein Forouzanfar et al. · The Lancet | Oct 2016 | 7,829 |
| 6 | Initial sequencing and comparative analysis of the mouse genome Asif T. Chinwalla et al. · Nature | Dec 2002 | 7,343 |
| 7 | PICRUSt2 for prediction of metagenome functions Gavin M. Douglas, Vincent J. Maffei, Jesse Zaneveld et al. · Nature Biotechnology | Jun 2020 | 7,006 |
| 8 | The International HapMap Project Richard A. Gibbs et al. · Nature | 18 Dec 2003 | 6,187 |
| 9 | Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference Stephen M. Smith, Thomas E. Nichols · NeuroImage | 12 Apr 2008 | 5,638 |
| 10 | Proposed minimum reporting standards for chemical analysis Lloyd W. Sumner et al. · Metabolomics | 11 Sep 2007 | 5,359 |
| 11 | Genetic studies of body mass index yield new insights for obesity biology The LifeLines Cohort Study et al. · Nature | 10 Feb 2015 | 4,954 |
| 12 | Drug repurposing: progress, challenges and recommendations Sudeep P. Pushpakom, Francesco Iorio, Patrick A. Eyers et al. · Nature Reviews Drug Discovery | 12 Oct 2018 | 4,863 |
| 13 | Structure validation by Cα geometry: ϕ,ψ and Cβ deviation Simon C. Lovell, Ian Davis, W.B. Arendall et al. · Proteins Structure Function and Bioinformatics | 8 Jan 2003 | 4,652 |
| 14 | Principles of biomedical ethics John Horton · Transactions of the Royal Society of Tropical Medicine and Hygiene | 2002 | 4,421 |
| 15 | FinnGen provides genetic insights from a well-phenotyped isolated population Mitja Kurki et al. · Nature | 18 Jan 2023 | 4,362 |
| 16 | Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease Robin P. Sherrington et al. · Nature | Jun 1995 | 4,080 |
| 17 | Permutation inference for the general linear model Anderson M. Winkler, Gerard R. Ridgway, Matthew Webster et al. · NeuroImage | 11 Feb 2014 | 3,891 |
| 18 | Core outcome measures for chronic pain clinical trials: IMMPACT recommendations Robert H. Dworkin et al. · Pain | 6 Nov 2004 | 3,789 |
| 19 | Biological, clinical and population relevance of 95 loci for blood lipids Tanya M. Teslovich et al. · Nature | Aug 2010 | 3,706 |
| 20 | Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study Karen L. Kotloff et al. · The Lancet | 13 May 2013 | 3,665 |
| 21 | Nitric oxide synthases: structure, function and inhibition Wendy K. ALDERTON, Chris E. Cooper, Richard G. Knowles · Biochemical Journal | Aug 2001 | 3,544 |
| 22 | A tutorial on pilot studies: the what, why and how Lehana Thabane, Jinhui Ma, Rong Chu et al. · BMC Medical Research Methodology | 6 Jan 2010 | 3,528 |
| 23 | Core outcome domains for chronic pain clinical trials: IMMPACT recommendations Dennis C. Turk et al. · Pain | 22 Sep 2003 | 3,518 |
| 24 | Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations Robert H. Dworkin et al. · Journal of Pain | 13 Dec 2007 | 3,496 |
| 25 | Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer Charles E. Geyer, John Forster, Deborah L. Lindquist et al. · New England Journal of Medicine | 27 Dec 2006 | 3,486 |
| 26 | Membrane transporters in drug development Kathleen M. Giacomini et al. · Nature Reviews Drug Discovery | Mar 2010 | 3,373 |
| 27 | Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry Warwick B. Dunn, David Broadhurst, Paul Begley et al. · Nature Protocols | 30 Jun 2011 | 3,360 |
| 28 | Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia Roger A. Fielding et al. · Journal of the American Medical Directors Association | 5 Mar 2011 | 3,319 |
| 29 | Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease PETER M. A. CALVERLEY, Julie A. Anderson, Bartolomé R. Celli et al. · New England Journal of Medicine | 21 Feb 2007 | 3,282 |
| 30 | Development and first validation of the COPD Assessment Test Paul Jones, Gale Harding, Pamela Berry et al. · European Respiratory Journal | 31 Aug 2009 | 3,269 |
| 31 | AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules David A. Pearlman, David Andrew Case, James W. Caldwell et al. · Computer Physics Communications | Sep 1995 | 3,156 |
| 32 | Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease John Robert Hurst, Jørgen Vestbo, Antonio R. Anzueto et al. · New England Journal of Medicine | 15 Sep 2010 | 3,024 |
| 33 | Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial Axel Hauschild et al. · The Lancet | 25 Jun 2012 | 3,009 |
| 34 | Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy Steven E. Kahn, Steven M. Haffner, Mark A. Heise et al. · New England Journal of Medicine | 4 Dec 2006 | 2,968 |
| 35 | Development of the asthma control test Robert A. Nathan, Christine A. Sorkness, Mark R. Kosinski et al. · Journal of Allergy and Clinical Immunology | 2004 | 2,939 |
| 36 | Principles of early drug discovery J. P. HUGHES, S. Rees, S. Barret Kalindjian et al. · British Journal of Pharmacology | 22 Nov 2010 | 2,906 |
| 37 | Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations Keith T. Flaherty et al. · New England Journal of Medicine | 30 Sep 2012 | 2,838 |
| 38 | Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib Caroline Robert et al. · New England Journal of Medicine | 16 Nov 2014 | 2,718 |
| 39 | New insights into the genetic etiology of Alzheimer’s disease and related dementias Céline Bellenguez et al. · Nature Genetics | Apr 2022 | 2,608 |
| 40 | A comprehensive map of molecular drug targets Rita Santos, Oleg Ursu, Anna Gaulton et al. · Nature Reviews Drug Discovery | 2 Dec 2016 | 2,546 |
| 41 | Drugs for bad bugs: confronting the challenges of antibacterial discovery David J Payne, Michael N. Gwynn, David J. Holmes et al. · Nature Reviews Drug Discovery | 8 Dec 2006 | 2,527 |
| 42 | A Resilient, Low-Frequency, Small-World Human Brain Functional Network with Highly Connected Association Cortical Hubs Sophie Achard, Raymond M. Salvador, Brandon J. Whitcher et al. · Journal of Neuroscience | 4 Jan 2006 | 2,492 |
| 43 | The Orphan G Protein-coupled Receptors GPR41 and GPR43 Are Activated by Propionate and Other Short Chain Carboxylic Acids Andrew J. Brown et al. · Journal of Biological Chemistry | Mar 2003 | 2,411 |
| 44 | Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs S Hong Lee et al. · Nature Genetics | 11 Aug 2013 | 2,374 |
| 45 | Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma Héctor Ortega, Mark C. Liu, Ian Douglas Pavord et al. · New England Journal of Medicine | 8 Sep 2014 | 2,339 |
| 46 | Opportunities and obstacles for deep learning in biology and medicine Travers H. Ching et al. · Journal of The Royal Society Interface | Apr 2018 | 2,322 |
| 47 | Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer Antonio González-Martı́n et al. · New England Journal of Medicine | 28 Sep 2019 | 2,318 |
| 48 | New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk Josée Dupuis et al. · Nature Genetics | 17 Jan 2010 | 2,239 |
| 49 | Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial Ian Douglas Pavord, Stephanie Korn, Peter Hugo Howarth et al. · The Lancet | Aug 2012 | 2,238 |
| 50 | CHEM21 selection guide of classical- and less classical-solvents Denis Prat, A.S. Wells, John D. Hayler et al. · Green Chemistry | 13 Aug 2015 | 2,229 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.